The CRM1 nuclear export receptor controls pathological cardiac gene expression

Brooke C Harrison1, Charles R Roberts, David B Hood

  • 1Myogen Inc., 7575 W. 103rd Ave., Westminister, CO 80021, USA. timothy.mckinsey@myogen.com

Insights

CRM1 facilitates pathological cardiac hypertrophy by exporting the antihypertrophic enzyme HDAC5 from cardiomyocyte nuclei. Blocking this export with CRM1 antagonists represses pathological gene expression and hypertrophy, suggesting therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Epigenetics

Background:

  • Pathological cardiac remodeling involves myocyte hypertrophy, leading to heart failure.
  • Subcellular distribution of transcriptional regulators controls pathological cardiac hypertrophy.
  • Nuclear export of transcription factors like NFAT and GATA is CRM1-dependent.

Purpose of the Study:

  • To investigate the role of histone deacetylase 5 (HDAC5) nuclear export in pathological cardiac hypertrophy.
  • To determine if CRM1 mediates HDAC5 nuclear export in response to hypertrophic stimuli.
  • To evaluate the therapeutic potential of targeting CRM1-dependent nuclear export.

Main Methods:

  • Studied the subcellular localization of HDAC5 in cardiomyocytes under hypertrophic conditions.
  • Utilized CRM1 antagonists to block nuclear export of HDAC5.
  • Assessed the effects of CRM1 inhibition on pathological gene expression and cardiomyocyte hypertrophy.
  • Compared CRM1's role in pathological vs. non-pathological cardiac gene activation.

Main Results:

  • HDAC5 is exported from the cardiomyocyte nucleus via a CRM1-mediated pathway in response to hypertrophic signals.
  • CRM1 antagonists inhibit agonist-induced HDAC5 nuclear export, repressing pathological gene expression and hypertrophy.
  • CRM1 activity is not required for non-pathological cardiac gene activation by thyroid hormone and IGF-1.

Conclusions:

  • CRM1 selectively promotes pathological cardiac gene expression by enabling the nuclear export of antihypertrophic factors like HDAC5.
  • Targeting CRM1-dependent nuclear export offers a potential therapeutic strategy for heart failure by suppressing maladaptive cardiac remodeling.

Related Concept Videos

Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...